Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Sesen Bio revenue
Sesen Bio's revenue is $19.6 million.
What is Sesen Bio's revenue?
- Sesen Bio's revenue growth from 2013 to 2024 is 1,371.66%.
- Sesen Bio has 35 employees, and the revenue per employee ratio is $560,914.
- Sesen Bio's peak quarterly revenue was $28.6M in 2016(q3).
- Sesen Bio peak revenue was $30.0M in 2016.
- Sesen Bio annual revenue for 2023 was 14.9M, 51.71% growth from 2022.
- Sesen Bio annual revenue for 2024 was 19.6M, 31.59% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Sesen Bio historical revenue
Sesen Bio's peak revenue was $30.0M in 2016. The peak quarterly revenue was $28.6M in 2016(q3).
Sesen Bio's revenue increased from $1.3m in 2013 to $19.6M currently. That's a 1,371.66% change in annual revenue.
Sesen Bio annual revenue
Sesen Bio annual revenue over time
| Fiscal year / year | Sesen Bio revenue |
|---|---|
| 2013 | $1.3M |
| 2014 | $2.2M |
| 2015 | $990,000 |
| 2016 | $30.0M |
| 2017 | $425,000 |
| 2020 | $11.2M |
| 2021 | $26.5M |
| 2022 | $9.8M |
| 2023 | $14.9M |
| 2024 | $19.6M |
How accurately did Sesen Bio's revenue projections match actual performance?
Sesen Bio annual growth
Sesen Bio saw the greatest revenue growth in 2016, when revenue increased by 2,928.38%.
Sesen Bio had the lowest revenue growth in 2017, when revenue changed by -98.58%.
Sesen Bio annual growth rate over time
| Year | Sesen Bio growth |
|---|---|
| 2014 | 68%↑ |
| 2015 | -56%↓ |
| 2016 | 2928%↑ |
| 2017 | -99%↓ |
| 2020 | 2544%↑ |
| 2021 | 136%↑ |
| 2022 | -63%↓ |
| 2023 | 52%↑ |
| 2024 | 32%↑ |
Sesen Bio quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Sesen Bio quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2013 | - | - | - | $510,000 |
| 2014 | $568,000 | $761,000 | $539,000 | $375,000 |
| 2015 | $244,000 | $114,000 | $67,000 | $565,000 |
| 2016 | $229,000 | $277,000 | $28.7M | $825,000 |
| 2017 | $425,000 | - | - | - |
| 2020 | - | - | $11.2M | - |
| 2021 | $4.3M | $2.2M | - | $20.0M |
| 2022 | $822,000 | $2.7M | $2.6M | $3.7M |
| 2023 | $3.2M | $3.6M | $3.8M | $4.3M |
| 2024 | $3.4M | $9.2M | $3.4M | $3.7M |
Sesen Bio jobs nearby
Do you work at Sesen Bio?
Is Sesen Bio transparent about its revenue structure?
Sesen Bio financial information
| CEO | Thomas Cannell |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 35 |
| Date Founded | 2010 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $19.6M |
| Net Income | -$19,884,000 |
| PE Ratio | -0.33 |
| Tax Rate | 0.1% |
| Market Capitalization | $19.9M |
| Total Assets | $72,153,000 |
| Ticker | SESN |
Sesen Bio jobs you might like
Sesen Bio financing
Sesen Bio received early financing of $35.0M on 2010.
| Series | Round size | Date |
|---|---|---|
| Equity | $996K | 2018 |
| Equity | $13.5M | 2016 |
| Equity | $20M | 2014 |
| Equity | $35M | 2010 |
Sesen Bio investors
| Investors | Security type |
|---|---|
| David Berry | |
| Karen L. Tubridy | |
| Jane Pritchett Henderson | |
| Daniel S. Lynch | |
| Reza Dana |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Sesen Bio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Sesen Bio. The employee data is based on information from people who have self-reported their past or current employments at Sesen Bio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Sesen Bio. The data presented on this page does not represent the view of Sesen Bio and its employees or that of Zippia.
Sesen Bio may also be known as or be related to Eleven Biotherapeutics Inc, Eleven Biotherapeutics, Inc. and Sesen Bio.